Brief overview of antibody–drug conjugate therapy for acute leukemia
Roland B. Walter
Abstract
KEYWORDS: Acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)antibody–drug conjugate gemtuzumab ozogamicininotuzumab ozogamicin
Topics & Concepts
Gemtuzumab ozogamicinAntibody-drug conjugateMyeloid leukemiaMedicineCalicheamicinConjugateDrugAntibodyLeukemiaLymphoblastic LeukemiaImmunoconjugateMonoclonal antibodyImmunologyPharmacologyCD33BiologyGeneticsStem cellMathematical analysisCD34MathematicsAcute Lymphoblastic Leukemia researchAcute Myeloid Leukemia ResearchCAR-T cell therapy research